Contracts Finder

NHS National Framework for Transition products commencing 1 October 2024

NHS England

Awarded
goods
SME-friendly
Framework agreement

Published on NHS Health Family Atamis procurement portal

This tender has closed

The submission deadline for this contract has passed. There may be more active goods tenders from NHS England, and hundreds more across the UK public sector.

Key details

Contracting authority
NHS England
nhs
Region
Runcorn, Cheshire
Sector
Healthcare & Medical
Contract value
£41,320,000ex VAT
Submissions closed
31 July 2024
Published
25 June 2024

Procurement

Contract period
1 October 2024 - 31 May 2026
2 years
Procedure type
Open procedure (above threshold)
CPV classifications
  • 33600000 Pharmaceutical products

What happened

NHS England awarded this contract to Thornton and Ross Ltd | Tillomed Laboratories ltd | Glenmark Pharmaceuticals Europe Limited | Gilead Sciences Limited | Amarox Limited | Mercury Pharmaceuticals Limited | Teva UK Limited | Zentiva Pharma UK Ltd | Accord-UK Ltd | Dr.Reddy's Laboratories (UK) Limited | Celix Pharma Ltd. | Seacross Pharmaceuticals Ltd worth £16,224,000 on 30 Sept 2024. The contract runs until 31 May 2026.

Description

Project title: NHS National Framework for Transition products commencing 1 October 2024 Offer reference number: CM/TNS/24/5712 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement:

CM/TNS/24/5712/01 - Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets Lot 1 CESW: 01/10/2024 to 30/09/2025 (12 months) Lot 2 NWLN: 01/10/2024 to 30/09/2025 (12 months) Lot 3 LSNE: 01/10/2024 to 31/05/2026 (20 months)

CM/TNS/24/5712/02 - Imatinib Lot 1 DSW: 01/10/2024 to 30/09/2025 (12 months)

Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Awarded suppliers (12)

Suppliers
  • Thornton and Ross Ltd
  • Tillomed Laboratories ltd
  • Glenmark Pharmaceuticals Europe Limited
  • Gilead Sciences Limited
  • Amarox Limited
  • Mercury Pharmaceuticals Limited
  • Teva UK Limited
  • Zentiva Pharma UK Ltd
  • Accord-UK Ltd
  • Dr.Reddy's Laboratories (UK) Limited
  • Celix Pharma Ltd.
  • Seacross Pharmaceuticals Ltd
Award value
£16,224,000
Award date
30 September 2024

Contact

Address
2nd Floor, Rutland House, Runcorn, Cheshire, WA7 2ES
Contact name
Katie Noonan
Email
[email protected]

Identifiers

Buyer reference
CF-2641700D0O000000rwimUAA
Notice ID
5ce17d64-f30a-47b5-916f-e45e3f31e0da-795000
OCID
ocds-b5fd17-fb0aeb89-2056-4b82-a415-3842e6b7e9c0

Explore related tenders

Other tenders from NHS England

View all →
Secondary Care Medicines Data Pre-Market Engagement£6,750,000
Targeted Prostate Cancer Screening Programme - MRI Reporting Service
Quality Assurance & Improvement of Structured Learning Placement (SLP) Modules£98,000
Targeted Prostate Cancer Screening Programme – PSA Laboratory Processing Service
Strengthening Cultural Capability and Trauma Informed Care in Women’s Health£175,000

External ID: cf-ocds-b5fd17-fb0aeb89-2056-4b82-a415-3842e6b7e9c0 • Added 3 October 2026